VEGFA and cancer: For this purpose, we determined plasma levels of VEGF with or without inhibition of platelet activation, and quantified VEGF release from platelets in vitro, in control persons without cancer, patients with metastatic non-renal cell carcinoma patients and patients with metastatic renal cell carcinoma.